Endothelial Cell–Activating Antibodies in COVID‐19

OBJECTIVE: While endothelial dysfunction has been implicated in the widespread thromboinflammatory complications of COVID‐19, the upstream mediators of endotheliopathy remain, for the most part, unknown. This study was undertaken to identify circulating factors contributing to endothelial cell activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hui, Zuo, Yu, Navaz, Sherwin, Harbaugh, Alyssa, Hoy, Claire K., Gandhi, Alex A., Sule, Gautam, Yalavarthi, Srilakshmi, Gockman, Kelsey, Madison, Jacqueline A., Wang, Jintao, Zuo, Melanie, Shi, Yue, Maile, Michael D., Knight, Jason S., Kanthi, Yogendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082472/
https://www.ncbi.nlm.nih.gov/pubmed/35174669
http://dx.doi.org/10.1002/art.42094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082472/
https://www.ncbi.nlm.nih.gov/pubmed/35174669
http://dx.doi.org/10.1002/art.42094

Ejemplares similares